Publications:
A selected list of publications:
Ãrbom Anders, Ahlstedt Jonas, Serén Tom, Auterinen Iiro, Kotiluoto Petri, Hauge HÃ¥vard, Ãstlund Karl, Olafsen Tove, Wu Anna M, Dahlbom Magnus, Strand Sven-Erik
Characterization of a double-sided silicon strip detector
autoradiography system
Medical physics,
2015; 42(2):
575-84.
Sonn Geoffrey A, Behesnilian Andrew S, Jiang Ziyue Karen, Zettlitz Kirstin A, Lepin Eric J, Bentolila Laurent, Knowles Scott M, Lawrence Daniel J P, Wu Anna M, Reiter Robert E
Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell
Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate
Cancer Xenografts in Real-Time
Clinical cancer research : an official journal of the American Association for Cancer Research,
2015; 5(12):
.
Watanabe Rira, Hanaoka Hirofumi, Sato Kazuhide, Nagaya Tadanobu, Harada Toshiko, Mitsunaga Makoto, Kim Insook, Paik Chang H, Wu Anna M, Choyke Peter L, Kobayashi Hisataka
Photoimmunotherapy targeting prostate-specific membrane antigen: are
antibody fragments as effective as antibodies?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
2015; 56(1):
140-4.
Watanabe Rira, Sato Kazuhide, Hanaoka Hirofumi, Harada Toshiko, Nakajima Takahito, Kim Insook, Paik Chang H, Wu Anna M, Choyke Peter L, Kobayashi Hisataka
Minibody-indocyanine green based activatable optical imaging probes:
the role of short polyethylene glycol linkers
ACS medicinal chemistry letters,
2014; 5(4):
411-5.
Knowles Scott M, Zettlitz Kirstin A, Tavaré Richard, Rochefort Matthew M, Salazar Felix B, Stout David B, Yazaki Paul J, Reiter Robert E, Wu Anna M
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and
124I-labeled anti-PSCA A11 minibody
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
2014; 55(3):
452-9.
Widney Daniel P, Olafsen Tove, Wu Anna M, Kitchen Christina M R, Said Jonathan W, Smith Jeffrey B, Peña Guadalupe, Magpantay Larry I, Penichet Manuel L, Martinez-Maza Otoniel
Levels of murine, but not human, CXCL13 are greatly elevated in
NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line,
2F7
PloS one,
2013; 8(8):
e72414.
Federman Noah, Chan Jason, Nagy Jon O, Landaw Elliot M, McCabe Katelyn, Wu Anna M, Triche Timothy, Kang Hyunggyoo, Liu Bin, Marks James D, Denny Christopher T
Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized
liposomal nanoparticles targeting the alcam cell surface receptor
Sarcoma,
2012; 2012(2):
126906.
Liu Kan, Lepin Eric J, Wang Ming-Wei, Guo Feng, Lin Wei-Yu, Chen Yi-Chun, Sirk Shannon J, Olma Sebastian, Phelps Michael E, Zhao Xing-Zhong, Tseng Hsian-Rong, Michael van Dam R, Wu Anna M, Shen Clifton K-F
Microfluidic-based 18F-labeling of biomolecules for immuno-positron
emission tomography
Molecular imaging,
2011; 10(3):
168-76, 1-7.
Sherman David J, Kenanova Vania E, Lepin Eric J, McCabe Katelyn E, Kamei Ken-Ichiro, Ohashi Minori, Wang Shutao, Tseng Hsian-Rong, Wu Anna M, Behrenbruch Christian P
A differential cell capture assay for evaluating antibody interactions
with cell surface targets
Analytical biochemistry,
2010; 401(2):
173-81.
Lepin Eric J, Leyton Jeffrey V, Zhou Yu, Olafsen Tove, Salazar Felix B, McCabe Katelyn E, Hahm Scott, Marks James D, Reiter Robert E, Wu Anna M
An affinity matured minibody for PET imaging of prostate stem cell
antigen (PSCA)-expressing tumors
European journal of nuclear medicine and molecular imaging,
2010; 37(8):
1529-38.
Lepin EJ, Leyton JV, Zhou Y, Olafsen T, Salazar FB, McCabe KE, Hahm S, Marks JD, Reiter RE, Wu AM
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
Eur J Nucl Med Mol Imaging,
2010; 37(8):
1529-38.
Olafsen Tove, Sirk Shannon J, Betting David J, Kenanova Vania E, Bauer Karl B, Ladno Waldemar, Raubitschek Andrew A, Timmerman John M, Wu Anna M
ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers
(diabodies)
Protein engineering, design & selection : PEDS,
2010; 23(4):
243-9.
Olafsen T, Young SG, Davies BS, Beigneux AP, Kenanova VE, Voss C, Young G, Wong KP, Barnes RH 2nd, Tu Y, Weinstein MM, Nobumori C, Huang SC, Goldberg IJ, Bensadoun A, Wu AM, Fong LG
Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning
J Biol Chem,
2010; 285(50):
39239-48.
Shimazaki, K. Chan, A. M. Moniz, R. J. Wadehra, M. Nagy, A. Coulam, C. P. Mareninov, S. Lepin, E. M. Wu, A. M. Kelly, K. A. Braun, J. Gordon, L. K.
Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model
Fems Immunology and Medical Microbiology,
2009; 55(2):
240-249.
Barat Bhaswati, Sirk Shannon J, McCabe Katelyn E, Li Jianqing, Lepin Eric J, Remenyi Roland, Koh Ai Leen, Olafsen Tove, Gambhir Sanjiv S, Weiss Shimon, Wu Anna M
Cys-diabody quantum dot conjugates (immunoQdots) for cancer marker
detection
Bioconjugate chemistry,
2009; 20(8):
1474-81.
Leyton, J.V., Olafsen, T., Sherman, M.A., Bauer, K.B., Aghajanian, P., Reiter, R.E., and Wu, A.M.
Engineered humanized diabodies for microPET imaging of prostate stem cell antigen (PSCA)-expressing tumors
Protein Engineering Design & Selection,
2009; 22:
209-216.
Frank Richard T, Edmiston Marissa, Kendall Stephen E, Najbauer Joseph, Cheung Chia-Wei, Kassa Thewodros, Metz Marianne Z, Kim Seung U, Glackin Carlotta A, Wu Anna M, Yazaki Paul J, Aboody Karen S
Neural stem cells as a novel platform for tumor-specific delivery of
therapeutic antibodies
PloS one,
2009; 4(12):
e8314.
Schipper, M. L. Iyer, G. Koh, A. L. Cheng, Z. Ebenstein, Y. Aharoni, A. Keren, S. Bentolila, L. A. Li, J. Q. Rao, J. H. Chen, X. Y. Banin, U. Wu, A. M. Sinclair, R. Weiss, S. Gambhir, S. S.
Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice
Small,
2009; 5(1):
126-134.
Olafsen Tove, Betting David, Kenanova Vania E, Salazar Felix B, Clarke Pat, Said Jonathan, Raubitschek Andrew A, Timmerman John M, Wu Anna M
Recombinant anti-CD20 antibody fragments for small-animal PET imaging
of B-cell lymphomas
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
2009; 50(9):
1500-8.
Kenanova, V.E., Barat, B., Olafsen, T., Chatziioannou, A., Herschman, H.R., Braun, J., and Wu, A.M.
Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging
Eur. J. Nucl. Med. Molec. Imaging,
2009; 36(1):
104-114.
Brown Robert H, Irvin Charles G, Allen Gilman B, Shapiro Steven D, Martin William J, Kolb Martin R J, Hyde Dallas M, Nieman Gary F, Cody Dianna D, Ishii Masaru, Kadlecek Stephen J, Driehuys Bastiaan, Rizi Rahim R, Wu Anna M, Weber Wolfgang A, Stout David B, Stout David B
An official ATS conference proceedings: advances in small-animal
imaging application to lung pathophysiology
Proceedings of the American Thoracic Society,
2008; 5(5):
591-600.
Shimazaki, K., Lepin, E.J., Wei, B., Nagy, A., Coulum, P., Mareninov, S., Fu, M., Wu, A.M., Marks, J.D., Braun, J., Gordon, L.K., and Wadehra, M.
Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines
Clin. Cancer Res,
2008; 14:
7367-7377.
Wei, L. H. Olafsen, T. Radu, C. Hildebrandt, I. J. Mccoy, M. R. Phelps, M. E. Meares, C. Wu, A. M. Czernin, J. Weber, W. A.
Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging
Journal of Nuclear Medicine,
2008; 49(11):
1828-1835.
Sirk, S., Olafsen, T., Barat, B., Bauer, K. B., McCabe, K.E., and Wu, A.M.
Site-specific thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2
Bioconjugate Chemistry,
2008; 19:
2527-2534.
Schipper, M.L., Cheng, Z., Lee, S.-W., Bentolila, L.A., Iyer, G., Rao, J., Chen, X., Wu, A.M., Weiss, S., and Gambhir, S.S.
MicroPET-based biodistribution of quantum dots in living mice
J. Nucl. Med,
2007; 48:
1511-1518.
Cai, W Olafsen, T Zhang, X Cao, Q Gambhir, SS Williams, LE Wu, AM Chen, X
PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
2007; 48(2):
304-10.
Kenanova, V. Olafsen, T. Williams, L. E. Ruel, N. H. Longmate, J. Yazaki, P. J. Shively, J. E. Colcher, D. Raubitschek, A. A. Wu, A. M.
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: Optimal pharmacokinetics for therapy
Cancer Research,
2007; 67(2):
718-726.
Olafsen, T. Gu, Z. Sherman, M. A. Leyton, J. V. Witkosky, M. E. Shively, J. E. Raubitschek, A. A. Morrison, S. L. Wu, A. M. Reiter, R. E.
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody
Journal of Immunotherapy,
2007; 30(4):
396-405.
Wong, J.Y.C., Chu, D.Z., Williams, L.E., Liu, A., Zhan, J., Yamauchi, D.M., Wilczynski, S., Wu, A.M., Yazaki, P.J., Shively, J.E., Leong, L., Raubitschek, A.A.
A Phase I trial of 90Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies
Cancer Biother. Radiopharm,
2006; 21:
88-100.
Li, L. Yazaki, P. J. Anderson, A. L. Crow, D. Colcher, D. Wu, A. M. Williams, L. E. Wong, J. Y. C. Raubitschek, A. Shively, J. E.
Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody
Bioconjugate Chemistry,
2006; 17(1):
68-76.
Olafsen, T. Kenanova, V. E. Sundaresan, G. Anderson, A. L. Crow, D. Yazaki, P. J. Li, L. Press, M. F. Williams, L. E. Wong, J. Y. C. Raubitschek, A. A. Shively, J. E. Wu, A. M.
Optimizing radiolabeled engineered anti-p185(HER2) antibody fragments for in vivo imaging
Cancer Research,
2005; 65(13):
5907-5916.
Michalet, X. Pinaud, F. F. Bentolila, L. A. Tsay, J. M. Doose, S. Li, J. J. Sundaresan, G. Wu, A. M. Gambhir, S. S. Weiss, S.
Quantum dots for live cells, in vivo imaging, and diagnostics
Science,
2005; 307(5709):
538-544.
Bentolila LA, Michalet X, Pinaud FF, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S
Quantum dots for molecular imaging and cancer medicine
Discov Med,
2005; 5(26):
213-8.
Kenanova, V. Olafsen, T. Crow, D. M. Sundaresan, G. Subbarayan, M. Carter, N. H. Ikle, D. N. Yazaki, P. J. Chatziioannou, A. F. Gambhir, S. S. Williams, L. E. Shively, J. E. Colcher, D. Raubitschek, A. A. Wu, A. M.
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments
Cancer Research,
2005; 65(2):
622-631.
Olafsen T, Tan GJ, Cheung CW, Yazaki PJ, Park JM, Shively JE, Williams LE, Raubitschek AA, Press MF, Wu AM
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting
Protein engineering, design & selection : PEDS,
2004; 17(4):
315-23.
Olafsen T, Cheung CW, Yazaki PJ, Li L, Sundaresan G, Gambhir SS, Sherman MA, Williams LE, Shively JE, Raubitschek AA, Wu AM
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
Protein engineering, design & selection : PEDS,
2004; 17(1):
21-7.
Yazaki, P. J. Sherman, M. A. Shively, J. E. Ikle, D. Williams, L. E. Wong, J. Y. C. Colcher, D. Wu, A. M. Raubitschek, A. A.
Humanization of the anti-CEA T84.66 antibody based on crystal structure data
Protein Engineering Design & Selection,
2004; 17(5):
481-489.
Wong, J. Y. C. Chu, D. Z. Williams, L. E. Yamauchi, D. M. Ikle, D. N. Kwok, C. S. Liu, A. Wilczynski, S. Colcher, D. Yazaki, P. J. Shively, J. E. Wu, A. M. Raubitschek, A. A.
Pilot trial evaluating an I-123-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer
Clinical Cancer Research,
2004; 10(15):
5014-5021.
Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM, Raubitschek AA, Williams LE, Chatziioannou AF, Gambhir SS, Wu AM
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice
Journal of nuclear medicine: Official Publication, Society of Nuclear Medicine,
2003; 44(12):
1962-9.
Wong Jeffrey Y C, Shibata Stephen, Williams Lawrence E, Kwok Cheuk S, Liu An, Chu David Z, Yamauchi Dave M, Wilczynski Sharon, Ikle David N, Wu Anna M, Yazaki Paul J, Shively John E, Doroshow James H, Raubitschek Andrew A
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66
radioimmunotherapy with 5-fluorouracil in patients with metastatic
colorectal cancer
Clinical cancer research : an official journal of the American Association for Cancer Research,
2003; 9(16 Pt 1):
5842-52.
Ye JJ, Liang SJ, Guo N, Li SL, Wu AM, Giannini S, Sachdev D, Yee D, Brünner N, Ikle D, Fujita-Yamaguchi Y
Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo
Horm Metab Res,
2003; 35(11-12):
836-42.
Dickersin K, Braun L, Mead M, Millikan R, Wu AM, Pietenpol J, Troyan S, Anderson B, Visco F
Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development)
Health Expect,
2001; 4(4):
213-20.
Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski S, Wu AM, Shively JE, Doroshow JH, Raubitschek AA
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies
Clin Cancer Res,
2000; 6(10):
3855-63.
Wu, A. M. Yazaki, P. J. Tsai, S. W. Nguyen, K. Anderson, A. L. McCarthy, D. W. Welch, M. J. Shively, J. E. Williams, L. E. Raubitschek, A. A. Wong, J. Y. C. Toyokuni, T. Phelps, M. E. Gambhir, S. S.
High-resolution microPET imaging of carcino-embryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
Proceedings of the National Academy of Sciences of the United States of America,
2000; 97(15):
8495-8500.
Jensen MC, Clarke P, Tan G, Wright C, Chung-Chang W, Clark TN, Zhang F, Slovak ML, Wu AM, Forman SJ, Raubitschek A
Human T lymphocyte genetic modification with naked DNA
Mol Ther,
2000; 1(1):
49-55.
Wong JY, Somlo G, Odom-Maryon T, Williams LE, Liu A, Yamauchi D, Wu AM, Yazaki P, Wilczynski S, Shively JE, Forman S, Doroshow JH, Raubitschek AA
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer
Clin Cancer Res,
1999; 5(10 Suppl):
3224s-3231s.
Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients
J Nucl Med,
1998; 39(12):
2097-104.
Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody
J Nucl Med,
1997; 38(12):
1951-9.
Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odom-Maryon T, Wong JY, Shively JE
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
Immunotechnology,
1996; 2(1):
21-36.
Wong JY, Williams LE, Yamauchi DM, Odom-Maryon T, Esteban JM, Neumaier M, Wu AM, Johnson DK, Primus FJ, Shively JE, et al
Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial
Cancer Res,
1995; 55(23 Suppl):
5929s-5934s.
Kashani-Sabet M, Funato T, Tone T, Jiao L, Wang W, Yoshida E, Kashfinn BI, Shitara T, Wu AM, Moreno JG, et al.
Reversal of the malignant phenotype by an anti-ras ribozyme
Antisense Res Dev,
1992; 2(1):
3-15.